The role of nitric oxide (NO) and ATP in the regulation of nonadrenergic, n
oncholinergic (NANC) inhibitory transmission in the pylorus remains unclear
. In the presence of atropine and guanethidine, electric field stimulation
induced NANC relaxations in a frequency-dependent manner (1-20 Hz) in the r
at pylorus. NANC relaxations were significantly inhibited by N-G-nitro-L-ar
ginine methyl ester (L-NAME; 10(-4) M). P-2X purinoceptor antagonist pyrido
xal phosphate-6-azophenyl-2',4'-disulfonic acid (PPADS; 3 x 10(-5) M) and P
-2Y purinoceptor antagonist reactive blue 2 (2 x 10(-5) M) had no effect on
NANC relaxations. However, the combined administration of L-NAME and PPADS
, but not reactive blue 2, evoked greater inhibitory effects on NANC relaxa
tion than that evoked by L-NAME alone. alpha-Chymotrypsin and vasoactive in
testinal polypeptide antagonist did not affect NANC relaxations. ATP (10(-5
) -10(-3) M) and P-2X purinoceptor agonist alpha,beta-methyleneadenosine 5'
-triphosphate (10(-7) -10(-5) M), but not P-2Y purinoceptor agonist 2-methy
l-thioadenosine 5'-triphosphate (10(-7) -10(-5) M), induced muscle relaxati
ons in a dose-dependent manner, and relaxations were significantly reduced
by PPADS and unaffected by TTX. These studies suggest that NO and ATP act i
n concert to mediate NANC relaxation of the rat pylorus. ATP-induced relaxa
tion appears to be mediated by P-2X purinoceptors located on smooth muscle
cells.